Minerva Neurosciences (NERV) Assets (2013 - 2026)

Minerva Neurosciences has reported Assets for 14 years, with the latest figure at $94.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 186.68% year-over-year to $94.0 million; the trailing twelve-month figure through Mar 2026 stood at $94.0 million (up 186.68% YoY), and the FY2025 full-year result was $98.0 million, up 163.76% from the prior year.
• Assets for Q1 2026 stood at $94.0 million, down from $98.0 million in the prior quarter.
• The five-year high for Assets was $98.0 million in Q4 2025, with the low at $28.1 million in Q3 2025.
• Historically, Assets has averaged $55.8 million across 5 years, with a median of $55.1 million in 2022.
• Annual changes were most pronounced in 2022 — Assets sank 38.75% — and 2026, when it soared 186.68%.
• Minerva Neurosciences' Assets stood at $55.1 million in 2022, then rose by 3.29% to $56.9 million in 2023, then plunged by 34.72% to $37.1 million in 2024, then jumped by 163.76% to $98.0 million in 2025, then slipped by 4.02% to $94.0 million in 2026.
• The last three Assets figures came in at $94.0 million (Q1 2026), $98.0 million (Q4 2025), and $28.1 million (Q3 2025), per Business Quant data.